The Food and Drug Administration (FDA) carried out an inspection of Ivf-Pgd Lab, LLC in Chicago on April 22, examining compliance in human cellular, tissue and gene therapy operations, according to data posted on the FDA’s website.
The findings from the final report showed that Ivf-Pgd Lab, LLC was not required to take corrective action regarding any of its managing operations.
The FDA regularly inspects facilities throughout the country to ensure workplaces and products comply with FDA laws and regulations focused on public health. Inspection outcomes are then made available to the public.
According to its website, the FDA is a government agency chiefly responsible for overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
